Suggesting an opportunity to combine statins with other agents, YAP1 collaborates with the targetable epigenetic regulator BRD4 [115] to regulate the chromatin accessibility of many genes, which influences their expression and contributes to the malignant properties of HNSCC [116]. The gene discussed is YAP1; the disease is head and neck squamous cell carcinoma.